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Objective. To assess the values of transcutaneous oxygen tension (TcPO2) capable of predicting above-the-ankle amputa-
tion in diabetic patients diagnosed for critical limb ischemia (CLI) according to the criteria of the TransAtlantic Inter-
Society Consensus.
Design. Retrospective study.
Methods. From January 1999 to December 2003, 564 diabetic patients were consecutively hospitalized for CLI in one limb.
Revascularization with angioplasty or bypass graft was performed when possible and, if not possible, prostanoid therapy
was used. In patients in whom therapies did not relieve the rest pain or the gangrene was extended above the Chopart joint,
an above-the-ankle-amputation was performed. After treatment TcPO2 values were evaluated in all patients at the dorsum
of the foot.
Results. Fifty-five (9.8%) patients underwent an above-the-ankle amputation: 22 of 420 patients who underwent angio-
plasty, 17 of 117 patients who underwent bypass (14.5%) and 16 of 27 patients in whom revascularization was not pos-
sible. Post-treatment TcPO2, measured by a receiver operating characteristic (ROC) curve, showed a value 34 mmHg as the
best threshold for determining the need for revascularization, with an area under the curve of 0.89 (95%CI 0.85e0.94).
Using logistic regression analysis the probability of above-the-ankle amputation for this threshold is 9.7% and reduces
to 3% for TcPO2> 40 mmHg.
Conclusion. TcPO2 levels< 34 mmHg indicate the need for revascularization, while for values  34< 40 mmHg this
need appears less pressing, although there remains a considerable probability of amputation. TcPO2 levels greater than
40 mmHg suggest that revascularization is dependent on the severity of tissue loss and possible morbidity caused by
the procedure.
Keywords: Diabetic foot; Peripheral arterial occlusive disease; Critical limb ischemia; TransAtlantic Inter-Society
Consensus parameters; Transcutaneous oxygen tension; Major amputation; Revascularization.In June 2000, the TransAtlantic Inter-Society Consen-
sus (TASC) defined the Critical Limb Ischemia (CLI)
as the presence of chronic ischemic rest pain, ulcer or
gangrene in the foot attributable to objectively proven
peripheral arterial occlusive disease (PAOD).1 For
objective criteria for diagnosis of rest pain, ulcer or
gangrene caused by the arterial occlusive disease the
use of either ankle pressure <50e70 mmHg or toe
pressure <30e50 mmHg, or transcutaneous oxygen
tension (TcPO2) <30e50 mmHg has been suggested.
In June 2007 a new version of TASC was edited.2 In
this edition the ankle and toe pressure thresholds
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of 30 mmHg was proposed.
Ankle and toe pressure measurements are assess-
able readily in non-diabetic patients, and therefore
they are regarded as optimal criteria for screening
this population group.3 In contrast, these measure-
ments are not easily assessable in diabetic patients
with critical limb ischemia and/or foot ulcer, where
tibial arteries are often poorly compressible due to
the presence of medial arterial calcifications (MAC)
and both tibial arteries may be occluded: as a conse-
quence of these anatomical abnormalities, the ankle
pressure assessment becomes impracticable.4,5 More-
over, ulcer or toe gangrene may frequently occur in
diabetic patients, thus preventing toe pressure mea-
surement. In our experience, ankle and toe systolic
pressure investigations cannot be evaluated inrved.
732 E. Faglia et al.almost 50% of diabetic patients with CLI and foot
ulcer, similar to the rate reported by Gibbons et al.6
Unlike ankle or toe pressure, transcutaneous oxi-
metry at the dorsum of the foot is easily assessable
in all diabetic subjects and therefore it can be regarded
as an useful parameter for diagnosis in the diabetic
population.7,8
The aim of this study is to investigate the diagnos-
tic efficacy of transcutaneous oxygen tension values in
predicting above-the-ankle amputation in a cohort of
diabetic patients consecutively hospitalized for rest
pain and/or foot ulcer and diagnosed for CLI accord-
ing to the TASC 2000 oxymetric criteria.
Patients and Methods
All diabetic patients referred to our Diabetic Foot Cen-
ter for foot lesions or rest pain were assessed for the
presence of sensory-motor neuropathy, infection and
peripheral arterial occlusive disease. Sensory-motor
neuropathy was detected by means of vibration per-
ception threshold >25 V at biothesiometer, insensitiv-
ity in >5/9 foot points at SemmeseWeinstein 10 g
filament, and absence of Achille’s tendon reflex. In
patients with foot ulcer local cellulitis, erythema or
purulence with positive swab culture was considered
as being the indicators of the presence of an infection.
Peripheral arterial disease was diagnosed if one
foot pulse was reduced or absent, ankle-pressure
was <70 mmHg when assessable (e.g. if foot arteries
were not absent or poorly compressible due to medial
calcifications), transcutaneous oxygen tension (TcPO2)
at the dorsum of the foot was <50 mmHg and
obstructions were identified at duplex scanning.
In all patients presenting with absent or reduced
pulses in at least one foot pulse, TcPO2< 50 mmHg,
ankle-pressure <70 mmHg and obstructions at
duplex scanning, arteriography was performed and,
when practicable, a percutaneous transluminal angio-
plasty (PTA) was performed concomitantly. In pa-
tients in whom PTA was attempted unsuccessfully,
a by-pass graft (BPG) was considered. Patients in
whom revascularization was not possible therapy
with prostanoids or lumbar sympathectomy plus
prostanoids was given when possible.
Above-the-ankle-amputation was considered and
performed, with patient consent, if therapies did not
relieve patients from rest pain or gangrene was ex-
tending beyond the Chopart joint. Limb salvage was
considered successful if the plantar standing was
maintained, even when achieved by tarsal-metatarsal
amputation.9,10 Conversely, any above-the-ankle am-
putation was deemed a failure. Only one limb wasEur J Vasc Endovasc Surg Vol 33, June 2007considered: possible contralateral limb problems
were not considered in this study.
TcPO2 measurement. In all patients TcPO2 measure-
ments in the ischaemic limb were taken at hospital
admission and then reassessed 5 days after PTA,
BPG, medical therapy or sympathectomy. In patients
who suffered an above-the-ankle amputation, the
TcPO2 level measured before the amputation proce-
dure was the value considered for analysis.
All TcPO2 measurements were taken at the dorsum
of the foot in the peri-lesional site with the patient rest-
ing in supine position, in air-conditioned room main-
tained at 22 C; the instrument used was a TCM3
(Radiometer GMBH, Cophenagen, Denmark) equip-
ped with a Clark electrode. The measuring site
was cleaned carefully using saline solution. The trans-
ducerwas fixed to the skinwith double-sided adhesive
rings and contact liquid supplied by the manufacturer.
The calibration period was 10 min and the TcPO2
signal was continuously recorded on paper for 30
minutes.
Statistical methods. Data are given as mean  stan-
dard deviation for continuous data, or as percentages
for discrete variables. Major amputation was defined
as an above-the-ankle amputation. The capability to
predict the outcome of limb salvage and major ampu-
tation was assessed by the area under the Receiver
Operating Characteristic (ROC) curve. The best cut-
point was located via the Youden index.11 The proba-
bility of above-the-ankle amputation on the basis of
the TcPO2 levels measured at the dorsum of the foot
was evaluated with a logistic model. The validation
of the indicator variables of high-risk of amputation
was performed by resorting to the split sample tech-
nique. By using random numbers supplied by the
statistical program, the cohort of patients was split
into training and testing samples of equal size. On
the training sample we tested a logistic regression
model for amputation rate. In both training and test-
ing samples the ability of the model in matching esti-
mated amputation rate and observed amputation rate
was evaluated by the Hosmer-Lemeshow goodness-
of-fit statistics.12
Statistical analysis was performed using Stata 9.0
SE statistical package (Statistics/Data Analysis, Stata
Corporation, 4905 Lakeway Drive, College Station,
Texas 77845 USA, 800-STATA-PC).
Results
FromJanuary 1, 1999 toDecember 31, 2003, a total of 564
consecutive diabetic patientswith rest pain and/or foot
ulcer, and with a pedal TcPO2 value lower than
733Predictive Values of Transcutaneous Oxygen Tension50 mmHg,were hospitalized at our Foot Center. Demo-
graphic and clinical characteristics of this study
population are reported in Table 1. Fig. 1 reports the
TcPO2 values distribution by 10 mmHg classes at the
entry in the study.
In all these subjects arteriography revealed the
presence of a stenosis narrowing >50% of the vessel
lumen in at least one artery of the ischemic limb.
The obstructions were located exclusively in the iliac-
femoral-popliteal arteries in 28 patients (5.0%), exclu-
sively in the infrapopliteal arteries in 137 subjects
(24.3%), in both iliac-femoral-popliteal and infrapopli-
teal arteries in 399 patients (70.7%).
A revascularization procedure was performed in
537 (95.2%) patients. Peripheral transluminal angio-
plasty (PTA) was carried out in 420 (74.5%) patients.
Concomitant femoral-popliteal and crural PTA was
performed in 151 patients: of these in 116 with angio-
plasty of one crural artery, more than one in 35
patients. Surgical bypass was performed in 117
(20.7%) patients. The bypass was axillo-femoral in
one patient, femoral-popliteal (16 PTFE, 45 vein graft)
in 61 patients, femoral-infrapopliteal (17 PTFE, 40
vein graft) in 57 patients. In 27 (4.8%) patients neither
a PTA nor a bypass was possible due to high surgical
risk or lack of outflow. In all these patients treatment
with prostanoids and percutaneous chemical sympa-
thectomy, under CT (computer tomography) scan
guidance was performed, when possible.
During the study a major amputation was per-
formed in 55 (9.8%) patients. Twenty-two amputa-
tions were performed in PTA patients, in 19 for
gangrene extended above the Chopart joint, in 1 for
acute distal thrombosis after PTA in a patient not
suitable for further endoluminal or surgical revascu-
larization, in 2 for gangrene of the heel. Seventeen
Table 1. Demographic and clinical characteristics of study popula-
tion (N[ 564)
Variable
Age (years) 70.0 9.6
Females/males (n) 198 (35.1%)/366 (64.9%)
Insulin/oral therapy (n) 342 (60.6%)/222 (39.4%)
Diabetes duration (years) 17.0 11.1
Sensory motor neuropathy (n) 465 (82.4%)
Retinopathy (n) 212 (37.6%)
Albumin excretion (mg/l) (n¼ 532) 259.8 529.7
Creatinine (mg/dl) (n¼ 532) 1.28 0.56
Wagner grade (n)
0 88 (15.6%)
1 83 (14.7%)
2 78 (13.8%)
3 55 (9.8%)
4 260 (46.1)
Infected ulcer (n) 362 (64.2%)
TcPO2 at admission (mmHg) 14.1 11.8amputations were performed in bypass patients
following graft occlusion. Sixteen amputations were
performed in non-revascularized patients for rest
pain and extensive gangrene. These 55 subjects are
referred as amputation patients. Fig. 2 describes the
intervention, amputation, loss to follow-up and death
of study population.
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Fig. 1. TcPO2 values distribution by 10 mmHg classes in
study population at the study entry (N¼ 564).
564 patients admitted from
January, 1999 to December, 2005
because of critical limb ischemia   
117 patients
revascularized 
with bypass graft
27 patients
with revascularization 
non feasible  
420 patients
revascularized 
with PTA
6  major amputation
at 30 days  
3 major amputation
at 30 days  
14 major amputation
at 30 days  
16 major amputation
during follow-up  
14 major amputation
during follow-up  
2 major amputation
during follow-up  
558 (98.9   ) patients  followed from
January 1st 1999 until June 30st 2005. 
173 (30.7    ) patients died during follow-up 
Fig. 2. Flow-chart of intervention, major amputation out-
come and death in study population.Eur J Vasc Endovasc Surg Vol 33, June 2007
734 E. Faglia et al.All non-amputated patients achieved pain relief
with discontinuation of antalgic therapy and regained
autonomic walking capability with the help of with
extra-deep rocker shoes provided with soft thermo-
formable leather and customized insoles.
The TcPO2 values by classes of 10 mmHg after the
therapy in cases of limb salvage or amputation are
given in Fig. 3. The discriminatory ability of TcPO2
values in patient selection for major amputation, mea-
sured by a receiver operating characteristic (ROC)
curve, indicated a value of 34 mmHg as best thresh-
old, on the basis of a Youden index of 160.6, sensitivity
78.6, specificity 83.0. The area under the curve was
0.89 (95%CI 0.85e0.94). Fig. 4 shows the ROC curve
for TcPO2.
The results of the logistic regression analysis per-
formed for the association of outcome in above-
the-ankle amputation and TcPO2 values showed an
odds ratio of 0.90 (95%CI 0.87e0.93) for increase of
1 mmHg of TcPO2, p< 0.001. The results by classes
of 10 mmHg are reported in Table 2. For TcPO2¼
34 mmHg, which was the best threshold on the ROC
curve, the logistic analysis indicated a 9.7% (95%CI
7.0e13.2) probability of above-the-ankle amputation.
Fig. 5 shows the performance of the logistic model.
The goodness-of-fit of this model was assessed by
the Hosmer-Lemeshow test: the c2 was 10.36 with
8 degrees of freedom and p¼ 0.24 for the testing
group, and c2¼ 8.20 with 8 degrees of freedom and
p¼ 0.41 for the training group.
Discussion
It is unquestioned that, in patients with CLI, the re-
vascularization procedure is of paramount impor-
tance for achieving successful pain relief and healing
of foot lesions.13,14 The critical issues appear to be
the parameters that are used to evaluate the CLI.
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Fig. 3. TcPO2 values by classes of 10 mmHg after therapy in
salvaged or amputated limb.Eur J Vasc Endovasc Surg Vol 33, June 2007These parameters should identify patients who would
with high probability of needing amputation in the
absence of other adequate therapies. This becomes
even more complicated in the diabetic population.
Both morphological and clinical characteristics of
diabetic patients with peripheral arterial occlusive
disease deeply differ from those of non diabetic sub-
jects.15 The development of ischaemic pain often is
attenuated or suppressed by a concomitant sensory
neuropathy and therefore the reduced sensation of
pain may underestimate the degree of the arterial
occlusive disease. Medial arterial calcification and ab-
sence of the foot pulses, due to the occlusion of both
tibial arteries, frequently occur in diabetic patients
and prevent ankle or toe pressure measurements.16
Moreover the toe pressure measurement was often
prevented by presence of a lesion. For all these rea-
sons, in our clinical practice we prefer to rely on the
oxymetric parameters, which are easily detectable in
all subjects.
By proposing the 30e50 mmHg interval, the TASC
2000 has indicated that a TcPO2 value <30 mmHg
might predict that healing will not occur. However,
a range of 30e50 mmHg was also indicated as being
useful in relation to the risk/benefit ratio of any
procedure.
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Fig. 4. ROC curve of TcPO2 after therapy in study popula-
tion (N¼ 564).
Table 2. Prediction probability of above-the-ankle amputation
evaluated by logistic regression analysis of TcPO2 values after
the therapy
TcPO2
values
(mmHg)
Prediction probability
of above-the-ankle
amputation
Confidence
interval
<10 68.0% 52.7e80.0
10< 20 44.0% 33.1e55.4
20< 30 22.5% 17.2e28.8
30< 40 6.1% 4.1e8.9
40< 50 2.6% 1.6e4.4
50< 60 0.8% 0.4e1.9
735Predictive Values of Transcutaneous Oxygen TensionIn TASC 2007, the definition of Critical Limb Ische-
mia (Recommendation 16) no longer included instru-
mental parameters. TASC 2007 cited the TcPO2 in D5.2
paragraph (Investigations) with just one value: ‘‘criti-
cal level<30 mmHg’’. As a consequence 70 (12.4%) pa-
tients of our series, who were presenting with TcPO2
values >30< 50 mmHg and underwent revasculari-
zation (without complications, fortunately) on the
basis of the TASC 2000 criteria, would have been
exposed to a pointless risk on the basis of TASC
2007 criteria.
The parameters obtained in our study from the
logistic analysis appear to be more articulate.
The ROC curve has indicated the TcPO2 value of
34 mmHg as the best threshold. This value is some-
what higher than the value of 30 mmHg pointed out
in TASC 2007. However, on logistic regression ana-
lysis this threshold was associated with a probability
of amputation which was close to 10% and, in our
opinion, accounts for the risk of a revascularization
procedure. According to the logistic regression ana-
lysis, only for TcPO2 values equal or higher than
40 mmHg did the probability of amputation fall below
3%. Therefore, for TcPO2> 40 mmHg the probability of
amputation is low enough to make an attempt at revas-
cularization non-mandatory: for a superficial, painless
ulcer intervention can be avoided, while infected gan-
grene requiring surgical intervention may guide the
clinician towards a revascularization strategy in order
to ensure the best healing results of the surgical
wound.17,18 In such cases, a careful assessment of
comorbidity, ulcer, and risk caused by the revascula-
rization procedure can help in selection of the thera-
peutic choice.
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Fig. 5. Probability of above-the-ankle amputation according
to TcPO2 values after therapy.In our analysis we considered the above-the-ankle
amputation as a major amputation and the amputation
at Chopart point as limb salvage with minor amputa-
tion. In the section ‘‘End Points/Outcome Reporting’’,
the TASC 2000 defines a major amputation as an
‘‘above the mid-forefoot amputation’’. In the TASC
2007 in the D7.4 (Management of ulcers) paragraph
only an above-the-ankle amputation was considered
amajor amputation.We agree with this new definition:
we believe that patients who underwent a Chopart
joint amputation and are able to ambulate for their
daily needs (such as using the bathroom at night) with-
out the need of crutches, prosthesis, or wheelchair,
should be regarded as subjects in whom the walking
capability is still maintained by a bipodalic support,
even if the plantar standing is partially lost.
Conclusions. On the basis of our data TcPO2<
34 mmHg indicates an unquestionable need for revas-
cularization, while for values  34< 40 mmHg this
need appears less pressing, although there remains
a considerable probability of amputation. TcPO2 levels
greater than 40 mmHg suggest that the revasculariza-
tion is optional, depending on severity of ulcer and
possible morbidity caused by the procedure. Only
for values >50 mmHg the amputation probability is
lower than 1% and revascularization is not necessary.
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